Form 4: Vertex Pharmaceuticals EVP Charles F. Wagner Jr. Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, sold 3,298 shares of common stock at $500 per share on March 10, 2025, under a pre-arranged trading plan.
Summary
- Charles F. Wagner Jr., the EVP & Chief Financial Officer of Vertex Pharmaceuticals, reported a transaction involving the company's common stock.
- On March 10, 2025, Wagner sold 3,298 shares of common stock at a price of $500 per share.
- The transaction was executed under a company-approved trading plan pursuant to Rule 10b5-1, which was established on August 8, 2024.
- Following the reported transaction, Wagner directly owns 51,671 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Sales by executives are a normal part of corporate governance. It is important to note that the sale was executed under a pre-arranged 10b5-1 trading plan, which allows corporate insiders to sell shares at predetermined times and prices to avoid accusations of insider trading.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Date Mr. Wagner's company approved trading plan under Rule 10b5-1 was entered into |
| 03/10/2025 | Date of the transaction where 3,298 shares of Common Stock were disposed of. |
| 03/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.